EB Pharma Developments
ActiveSummary
EB Pharma Developments has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,298 and a net result of -€1,347. Equity is shrinking by ~27% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2027. Its solvency ranks better than 40% of 779 sector peers (NACE 74, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Register details
Identification
Legal formPrivate limited company
Founded21-01-2022
Fiscal year end31-12
Activities, NACEBEL 2025
74999Other professional, scientific and technical activities
72101Research and development on biotechnology
72109Other research and development on natural sciences
E-invoicing
Reachable via Peppol
Peppol ID
0208:0780755671
Also
9925:BE0780755671
Registered
23-04-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 7 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Alken · 1 establishment unit since 2022
Ground area
1,294 m²
Building footprint
443 m²
Volume, LiDAR
2,153 m³
Parcel 73302E1060/00A002, Flanders · tallest building 9.7 m, ±1 floor. Linked by address, not a title deed.
4
companies at this address
See who is registered here
1 establishment unit
EB Pharma Developments
since 2022unit no. 2.327.009.214
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73302E1060/00A002 | Flanders | 1,293 m² | 1 · 443 m² | 9.7 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.